Literature DB >> 8175993

Application of purified bone morphogenetic protein (BMP) in cranio-maxillo-facial surgery. BMP in compromised surgical reconstructions using titanium implants.

H F Sailer1, E Kolb.   

Abstract

After a review of the clinically relevant literature on early modified whole bone products (demineralized bone; AAA bone (Urist et al., 1975))--predecessors of purified bone morphogenetic protein (BMP)--and a summary of the only published clinical experience with purified human BMP (in orthopedic surgery; from the group of Urist; Johnson et al., 1988-1992), an introductory overview of our experience with our own preparations of BMP from bovine bone in 271 procedures on the face and cranium in 145 patients is presented. In this first article of a series of three, major preprosthetic reconstructions using iliac bone grafts and titanium screw implants are described. All patients are examples of compromised bone and/or soft tissue conditions and cannot be considered routine indications for the operations performed. The most endangered implants became osseointegrated after 6 to 8 1/2 months as judged from clinical examination and CT imaging. These results demonstrate the efficacy of purified, concentrated BMP preparations, able unequivocally to induce bone even in areas with seemingly lost implants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175993     DOI: 10.1016/s1010-5182(05)80289-6

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  7 in total

Review 1.  [Osteoinduction and -reparation].

Authors:  N R Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  1997-02

Review 2.  Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives.

Authors:  Cornelius von Wilmowsky; Tobias Moest; Emeka Nkenke; Florian Stelzle; Karl Andreas Schlegel
Journal:  Oral Maxillofac Surg       Date:  2013-02-24

3.  Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications.

Authors:  Yupeng Chen; Thomas J Webster
Journal:  J Biomed Mater Res A       Date:  2009-10       Impact factor: 4.396

4.  Postoperative Cyst Associated with Bone Morphogenetic Protein Use in Posterior and Transforaminal Lumbar Interbody Fusion Managed Conservatively: Report of Two Cases.

Authors:  Eli M Baron; Diana M Mejía; Doniel Drazin; Neel Anand
Journal:  Cureus       Date:  2016-02-07

5.  Digital subtraction radiographic analysis of the combination of bioabsorbable membrane and bovine morphogenetic protein pool in human periodontal infrabony defects.

Authors:  Maria do Carmo Machado Guimarães; Euloir Passanezi; Adriana Campos Passanezi Sant'Ana; Sebastião Luiz Aguiar Grechi; Mario Taba Junior
Journal:  J Appl Oral Sci       Date:  2010 Jul-Aug       Impact factor: 2.698

6.  Image Guidance-Assisted Decompression and Removal of Heterotopic Ossification Following the Use of Recombinant Human Bone Morphogenetic Protein-2 in Transforaminal Lumbar Interbody Fusion.

Authors:  Julie L Chan; Robert A Ravinsky; J Patrick Johnson; Eli M Baron
Journal:  Cureus       Date:  2021-11-30

Review 7.  Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized stem cell therapy.

Authors:  Kristofer E Chenard; Chad M Teven; Tong-Chuan He; Russell R Reid
Journal:  J Biomed Biotechnol       Date:  2012-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.